| __timestamp | Supernus Pharmaceuticals, Inc. | Viking Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 72471000 | 1244910 |
| Thursday, January 1, 2015 | 89204000 | 5029636 |
| Friday, January 1, 2016 | 106010000 | 4846776 |
| Sunday, January 1, 2017 | 137905000 | 5329003 |
| Monday, January 1, 2018 | 159888000 | 7121000 |
| Tuesday, January 1, 2019 | 158425000 | 9128000 |
| Wednesday, January 1, 2020 | 200677000 | 10731000 |
| Friday, January 1, 2021 | 304759000 | 10701000 |
| Saturday, January 1, 2022 | 377221000 | 16121000 |
| Sunday, January 1, 2023 | 336361000 | 37021000 |
Igniting the spark of knowledge
In the competitive landscape of biopharmaceuticals, effective cost management is crucial. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of Viking Therapeutics, Inc. and Supernus Pharmaceuticals, Inc. over the past decade. From 2014 to 2023, Supernus Pharmaceuticals has seen a staggering 364% increase in SG&A expenses, peaking in 2022. This growth reflects their aggressive market expansion and investment in operational infrastructure. In contrast, Viking Therapeutics, while maintaining a more conservative fiscal approach, has experienced a 2,873% surge in SG&A expenses, indicating a strategic shift towards scaling operations. Notably, 2023 marks a pivotal year for Viking, with expenses reaching their highest, suggesting a potential ramp-up in market activities. This comparative insight underscores the diverse strategies employed by these companies in navigating the complex biopharma sector.
SG&A Efficiency Analysis: Comparing AstraZeneca PLC and Supernus Pharmaceuticals, Inc.
Neurocrine Biosciences, Inc. or Supernus Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Incyte Corporation and Viking Therapeutics, Inc.: SG&A Spending Patterns Compared
Summit Therapeutics Inc. or Supernus Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Bio-Techne Corporation or Viking Therapeutics, Inc.: Who Manages SG&A Costs Better?
Blueprint Medicines Corporation vs Supernus Pharmaceuticals, Inc.: SG&A Expense Trends
Cost Management Insights: SG&A Expenses for Corcept Therapeutics Incorporated and Viking Therapeutics, Inc.
Who Optimizes SG&A Costs Better? Viking Therapeutics, Inc. or Catalyst Pharmaceuticals, Inc.
Viking Therapeutics, Inc. and Mesoblast Limited: SG&A Spending Patterns Compared
Viking Therapeutics, Inc. and Evotec SE: SG&A Spending Patterns Compared
Viking Therapeutics, Inc. or Viridian Therapeutics, Inc.: Who Manages SG&A Costs Better?
Supernus Pharmaceuticals, Inc. and MannKind Corporation: SG&A Spending Patterns Compared